Astrotech Corporation reported a highly lopsided QQ1 2025 revenue result, underscoring the company’s ongoing transition from a product-led development model to a licensing- and collaborations-driven monetization strategy. Revenue came in at $34,000, down approximately 92% year over year and 54% quarter over quarter, with gross profit of $9,000 on a gross margin of 26.47%. The quarter was characterized by a deliberate tilt toward R&D and platform development across the three segments: Astrotech Technologies Inc. (ATI) licensing and platform commercialization of AMS Technology, 1st Detect (explosives trace detectors), and AgLAB (cannabis/hemp analytics). This resulted in an operating loss of $3.628 million and a net loss of $3.278 million, or $2.01 per share. EBITDA was negative $3.36 million, reflecting the early-stage nature of the business model and the absence of significant near-term product sales.